Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Sensorion
company
About
Sensorion is a France-based biopharmaceutical company developing targeted therapeutic solutions for the treatment of vestibular deficits.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- €4M
- Industries
- Biopharma,Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2009
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Sensorion, a Clapiers, France-based biopharmaceutical company specifically dedicated to the development of innovative and targeted therapeutic solutions to treat vestibular deficits.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€4M
Sensorion has raised a total of
€4M
in funding over 2 rounds. Their latest funding was raised on
Jan 21, 2015 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 21, 2015 | Series Unknown | €4M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Sensorion is funded by 2 investors.
InnoBio Fund
and Inserm Transfert Initiative
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
InnoBio Fund
|
— | Series Unknown |
Inserm Transfert Initiative
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
